Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment

Approximately 90 % of patients who die of prostate cancer (PCa) have bone metastases, often promoting osteoblastic lesions. We observed that 88 % of castration-resistant PCa (CRPC) bone metastases express prostatic acid phosphatase (PAP), a soluble secreted protein expressed by prostate epithelial c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Larson, Sandy R., Chin, Jessica, Zhang, Xiaotun, Brown, Lisha G., Coleman, Ilsa M., Lakely, Bryce, Tenniswood, Martin, Corey, Eva, Nelson, Peter S., Vessella, Robert L., Morrissey, Colm
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3946934/
https://ncbi.nlm.nih.gov/pubmed/24242705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-013-9625-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky